Genmab A/S annual operating margin
2017
2018
2019
Genmab A/S's operating margin was 49.16% for fiscal 2019.
View full Genmab A/S company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2019 | 2019-12-31 | 49.16% | +3.54 pp |
| 2018 | 2018-12-31 | 45.62% | −11.21 pp |
| 2017 | 2017-12-31 | 56.83% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2024 · Jun 30 | 2024-06-30 | 30.36% | −52.14 pp |
| Q2 2024 · Jun 30 | 2023-06-30 | 35.21% | +17.51 pp |
| Q2 2023 | 2022-06-30 | 39.44% | +12.94 pp |
| Q2 2022 | 2021-06-30 | 39.91% | — |
| Q2 2020 | 2020-06-30 | 82.50% | — |
| Q2 2019 | 2019-06-30 | 17.70% | — |
| Q2 2018 | 2018-06-30 | 26.50% | — |
Across the available reported history, Genmab A/S's operating margin increased from 45.62% to 49.16%, a change of +3.54 percentage points. The latest reported quarter, Q2 2024 · Jun 30, shows 30.36%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genmab A/S filings at SEC.gov ↗